Diagnostic Testing, Medical Imaging and Pharmaceutical Markets to See Dramatic Growth
(firmenpresse) - NEW YORK, NY -- (Marketwire) -- 08/22/12 -- TriMarkPublications.com cites in its newly updated report bundles that the diagnostic testing, medical imaging and pharmaceutical markets will see dramatic growth. For more information, visit: .
The Cancer Reports Bundle covers:
Biomarker Technology Platforms for Cancer Diagnoses and Therapies
Cancer Cell Therapy
Cancer Diagnostic Testing
Cancer Therapeutics
Cancer Vaccines
Companion Diagnostics in Personalized Medicine and Cancer Therapy
Cytology and HPV Testing
Game Changers in Breast Cancer Therapies
Molecular Diagnostics in Cancer Testing
The Diagnostics Reports Bundle covers:
Cancer Diagnostic Testing
Cardiac Marker Diagnostic Testing
Companion Diagnostics in Personalized Medicine and Cancer Therapy
European Point of Care (POC) Diagnostic Testing
High-Growth Diagnostic Testing
Key Diagnostic Testing
Molecular Diagnostics in Cancer Testing
Molecular Diagnostics in Infectious Disease Testing
Molecular Diagnostics
Over-the-Counter (OTC) Diagnostic Products
POC Diagnostic Testing Sector Trends
POC Diagnostic Testing
Women's Health Diagnostic Testing
The Genetics Reports Bundle covers:
Bioinformatics
DNA Sequencing and PCR
Gene Expression Reagents
Genomics
Microarray
Personalized Medicine
Pharmacogenomics for Clinical Use and in Drug Development
Regenerative Medicine
RNA Interference
Stem Cell
The Medical Devices Reports Bundle covers:
Cardiac Rhythm Management Devices
Catheter
Disposable Medical Supplies
Disposable Syringe
Home Medical Testing Devices
Orthopedics
Patient Monitoring
Plastic Surgery
Respiratory Therapeutics and Devices
Sleep Disorders
The Medical Imaging Reports Bundle covers:
European Medical Imaging
Mammography
Medical Imaging
Nuclear Cardiology
Picture Archiving and Communications Systems (PACS)
Positron Emission Tomography (PET)
Ultrasound
The Molecular Diagnostics Reports Bundle covers:
Molecular Diagnostics in Cancer Testing
Molecular Diagnostics in Infectious Disease Testing
Molecular Diagnostics
The Pharmaceuticals Reports Bundle covers:
Anti-Infective Drugs
Cell Therapy
Cell-Based Assays for Drug Discovery
Companion Biomarkers in Drug Development
Indian Pharmaceutical Industry
Medical Nanotechnology
Pharmacogenomics for Clinical Use and in Drug Development
Therapeutic Monoclonal Antibodies
The Cancer, Diagnostics, Genetics, Medical Devices, Medical Imaging, Molecular Diagnostics and Pharmaceuticals Report Bundles examine companies manufacturing cancer, diagnostics, genetics, medical device, medical imaging, molecular diagnostics and pharmaceutical equipment and supplies in the world. Companies covered include: 3M, Abbott, AstraZeneca, Bain, Bayer, Bayer, BD, Beckman Coulter, Bio-Rad, Bristol-Myers Squibb, Canon, Carl Zeiss, ETRI, FUJIFILM, Fujirebio, GE, Hitachi, Intel, Invitrogen, Johnson & Johnson, L.E.K., LG, Luminex, McKinsey, Novartis, Olympus, OraSure, Panasonic, PerkinElmer, Philips, QIAGEN, Roche, Rosetta, Samsung, Seventh Sense, Siemens, Sony, Sysmex and Toray.
Detailed charts with sales forecasts and marketshare data are included. For more information, visit: .
TriMarkPublications.com is a global leader in the biotechnology, healthcare and life sciences market research publishing. For more information, please visit .
TriMarkPublications.com
Media Relations
1-888-OK-TRIMARK
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 22.08.2012 - 17:45 Uhr
Sprache: Deutsch
News-ID 176896
Anzahl Zeichen: 0
contact information:
Town:
NEW YORK, NY
Kategorie:
Information Services
Diese Pressemitteilung wurde bisher 316 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Diagnostic Testing, Medical Imaging and Pharmaceutical Markets to See Dramatic Growth"
steht unter der journalistisch-redaktionellen Verantwortung von
TriMarkPublications.com (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
